This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-report: Archive
Trimble (TRMB) Down 9.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Trimble (TRMB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TRMBPositive Net Change GNRCPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Tronox (TROX) Down 7.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Tronox (TROX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TROXPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Why Is Uber (UBER) Down 5.9% Since Last Earnings Report?
by Zacks Equity Research
Uber (UBER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UBERPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Why Is United Therapeutics (UTHR) Down 3.8% Since Last Earnings Report?
by Zacks Equity Research
United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UTHRPositive Net Change CORTNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Essential Utilities (WTRG) Down 2.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Essential Utilities (WTRG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
WTRGPositive Net Change CWTPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Recursion Pharmaceuticals (RXRX) Up 16.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Recursion Pharmaceuticals (RXRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
RXRXPositive Net Change ILMNNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
SolarEdge (SEDG) Up 89.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
SolarEdge (SEDG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SEDGPositive Net Change ENPHPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Steven Madden (SHOO) Up 12.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Steven Madden (SHOO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SHOOPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Why Is Perrigo (PRGO) Down 9% Since Last Earnings Report?
by Zacks Equity Research
Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PRGONegative Net Change ZBHNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Qiagen (QGEN) Up 12.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
QGENNegative Net Change GSKPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate